A prospective, randomized, partially-blinded, placebo-controlled, phase III, multicenter trial to assess safety, tolerability and immunogenicity of liquid CAIV-T [influenza virus vaccine live] administered concomitantly with OPV [oral poliovirus vaccine; poliovirus vaccine live oral] in healthy children
Latest Information Update: 15 Oct 2009
At a glance
- Drugs Influenza virus vaccine live (Primary) ; Poliovirus vaccine live oral
- Indications Influenza virus infections; Poliomyelitis
- Focus Pharmacodynamics
- Sponsors MedImmune
- 04 Sep 2009 Results were published in Vaccine.
- 01 Nov 2006 New trial record.